Postantibiotic effect of trovafloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis in cerebrospinal fluid and broth culture media

Diagnostic Microbiology and Infectious Disease

Volumn 36, Issue 4, 2000, Pages 241-247

  Tessier, Pamela R ^a   Nightingale, Charles H ^a,b   Nicolau, David P ^a,b  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TROVAFLOXACIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID; CONTROLLED STUDY; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA MENINGITIDIS; NONHUMAN; POSTANTIBIOTIC EFFECT; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ANTI-INFECTIVE AGENTS; CEREBROSPINAL FLUID; CULTURE MEDIA; FLUOROQUINOLONES; HAEMOPHILUS INFLUENZAE; HUMANS; MICROBIAL SENSITIVITY TESTS; NAPHTHYRIDINES; NEISSERIA MENINGITIDIS; STREPTOCOCCUS PNEUMONIAE;

EID: 0034070566     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(99)00148-0     Document Type: Article

References (21)

1. Boswell F.J., Andrews J.M., Wise R. Postantibiotic effect of trovafloxacin on Pseudomonas aeruginosa. J Antimicrob Chemother. 39:1997;811-814.
2. Boswell F.J., Andrews J.M., Wise R. Pharmacodynamic properties of BAY 12-8039 on Gram-positive and Gram-negative organisms as demonstrated by studies of time-kill kinetics and postantibiotic effect. Antimicrob Agents Chemother. 41:(6):1997;1377-1379.
3. th ed. Baltimore: Williams & Wilkins, pp. 296-329.
4. Cutler N.R., Vincent J., Jhee S.S., Teng R., Wardle T., Lucas G., Dogolo L.C., Sramek J.J. Penetration of trovafloxacin into cerebral spinal fluid in humans following intravenous infusion of alatrovafloxacin. Antimicrob Agents Chemother. 41:1997;1298-1300.
5. Doern G.V. Trovafloxacin-a new extended-spectrum fluoroquinolone with real potential for the management of infections due to Streptococcus pneumoniae. Formulary. 33:(suppl 3):1998;S21-S26.
6. Fuchs P.C., Barry A.L., Brown S.D. Streptococcus pneumoniae killing rate and post-antibiotic effect of levofloxacin and ciprofloxacin. J Chemother. 9:(6):1997;391-393.
7. Giamarellou-Bourboulis E.J., Sambatakou H., Grecka P., Chryssouli Z., Giamarellou H. Sitafloxacin (DU-6859a) and Trovafloxacin Postantibiotic effect and in vitro interactions with rifampin a methicillin-resistant Staphylococcus aureus . Diagn Microbiol Infect Dis. 34:1999;301-307.
8. Gould I.M. Pharmacodynamics and the relationship between in vitro and in vivo activity of antimicrobial agents. J Chemother. 9:(suppl 1):1997;74-83.
9. Hopkins, S., Williams, D., Dunne, M., Marinovich, L., Edeline, M., Utt, E., & Dutse, A. I. (1996). A randomized, controlled trial of oral and IV trovafloxacin vs. ceftriaxone in the treatment of epidemic meningococcal meningitis. Proceedings of the 37th Interscience Conference on Antimicrob Agents and Chemother (LB21), New Orleans, LA.
10. Jones R.N., Pfaller M.A., Doern G.V. Comparative antimicrobial activity of trovafloxacin tested against 3049 Streptococcus pneumoniae isolates from the 1997-1998 respiratory infection season. Diagn Microbiol Infect Dis. 32:1998;119-126.
11. Karlowsky J.A., Zhanel G.G., Davidson R.J., Zieroth S.R., Hoban D.J. In vitro postantibiotic effects following multiple exposures of cefotaxime, ciprofloxacin and gentamicin against Escherichia coli in pooled human cerebrospinal fluid and mueller-hinton broth. Antimicrob Agents Chemother. 37:1993;1154-1157.
12. Kim Y.S., Liu Q., Chow L.L., Tauber M.G. Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother. 41:1997;1186-1189.
13. Licata L., Smith C.E., Goldschmidt R.M., Barrett J.F., Frosco M. Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae. Antimicrob Agents Chemother. 41:1997;950-955.
14. Lutsar I., McCracken J.M. Jr, Friedland I.R. Antibiotic pharmacodynamics in cerebrospinal fluid. Clinical Inf Dis. 27:1998;1117-1129.
15. MacKenzie F.M., Gould I.M. The post-antibiotic effect. J Antimicrob Chemother. 32:1993;519-537.
16. Nau R., Schmidt T., Kaye F., Froula J.L., Tauber M.G. Quinolone antibiotics in therapy of experimental pneumococcal meningitis in rabbits. Antimicrob Agents Chemother. 39:1995;593-597.
17. Pankuch G.A., Jacobs M.R., Appelbaum P.C. Postantibiotic effect of trovafloxacin against Gram-positive and -negative organisms. Antimicrob Agents Chemother. 42:1998;1503-1505.
18. Paris M.M., Hickey S.M., Trujillo M., Shelton S., McCracken G.H. Jr. Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother. 39:1995;1243-1246.
19. Spangler S.K., Lin G., Jacobs M.R., Appelbaum P.C. Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 Pneumococci. Antimicrob Agents Chemother. 42:1998;1253-1255.
20. Zhanel G.G., Karlowsky J.A., Davidson R.J., Hoban D.J. Effect of pooled human cerebrospinal fluid on the postantibiotic effects of cefotaxime, ciprofloxacin and gentamicin against Escherichia coli. Antimicrob Agents Chemother. 36:1992;1136-1139.
21. Zhanel G.G., Karlowsky J.A., Davidson R.J., Hoban D.J. Influence of human urine on the postantibiotic effect (PAE) of ciprofloxacin against Escherichia coli. Antimicrob Agents Chemother. 37:1991;218-223.